Atara Biotherapeutics (ATRA) Amortizatization of Intangibles (2014 - 2026)

Atara Biotherapeutics (ATRA) has 10 years of Amortizatization of Intangibles data on file, last reported at $814000.0 in Q1 2026.

• Quarterly Amortizatization of Intangibles fell 4.46% year-over-year to $814000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 million (down 9.58% YoY) and the FY2025 annual result came in at $3.6 million, down 12.92% from the prior year.
• Amortizatization of Intangibles retreated to $814000.0 in Q1 2026, from $878000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $1.3 million in Q3 2023 to a low of $814000.0 in Q1 2026.
• A 4-year average of $1.0 million and a median of $1.0 million in 2024 frame the typical range for Amortizatization of Intangibles.
• Annual changes were most pronounced in 2025 — Amortizatization of Intangibles declined 18.55% — and 2026, when it decreased 4.46%.
• Tracing ATRA's Amortizatization of Intangibles over 4 years: stood at $1.1 million in 2023, then dropped by 12.61% to $929000.0 in 2024, then declined by 5.49% to $878000.0 in 2025, then retreated by 7.29% to $814000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $814000.0 (Q1 2026), $878000.0 (Q4 2025), and $891000.0 (Q3 2025), per Business Quant data.